Bruce Ling

Bruce Ling is a Senior Research Scientist in the Department of Pediatrics - Neonatology at Stanford University School of Medicine. He holds an academic appointment as Assistant Professor in Surgery and is affiliated with multiple Stanford research institutes including Bio-X, Cardiovascular Institute, Maternal & Child Health Research Institute (MCHRI), and Stanford Cancer Institute.

• B.S., Biochemistry, Fudan University, China (1990)
• M.A., Molecular and Developmental Biology, UCLA, US (1994)
• Ph.D., Biological Chemistry, UCLA, US (1996)
• Postdoctoral Training in Medicine/Oncology/Computer Science, Stanford University, US (1996-1998)
• Business Administration, Leavey School of Business, Santa Clara University, US (2000-2001)

Bruce Ling's research focuses on hypothesis-driven, big data empowered translational sciences, particularly in

• Multi-omics analysis for disease biomarker discovery in neonatology and pediatrics
• Precision medicine through next-generation sequencing integration
• Development of clinical sensor technologies for urine-based diagnostics
• Deep learning applications in echocardiograms and pathological imaging

His work has produced 15 recent publications spanning Kawasaki disease treatment optimization, preterm birth risk prediction, PCNSL diagnostics, metabolic aging clocks for cancer relapse, and wearable device validation for pediatric arrhythmias.

Key contributions include

• Noninferiority trial demonstrating IVIG monotherapy sufficiency for Kawasaki disease
• High-resolution metabolomic models for early preeclampsia and preterm birth detection
• Multi-omics frameworks for colorectal cancer and ovarian cancer biomarkers
• Computer-aided pathology systems for echocardiographic mitral regurgitation detection

His research integrates liquid biopsy, machine learning, and high-throughput proteomics across maternal-fetal medicine, oncology, and cardiovascular disease applications.